William D. Waddill - Apr 15, 2024 Form 4 Insider Report for Turnstone Biologics Corp. (TSBX)

Role: Director
Signature: /s/ Venkat Ramanan, Attorney-in-Fact
Stock symbol: TSBX
Transactions as of: Apr 15, 2024
Transactions value $: $0
Form type: 4
Date filed: 4/16/2024, 05:38 PM
Previous filing: Mar 1, 2024
Next filing: Jul 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TSBX	Stock Option (Right to Buy)	Award	$0	+25.5K		$0.00	25.5K	Apr 15, 2024	Common Stock	25.5K	$2.81	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Thirty three and thirty three one hundreds percent (33.33%) (and thirty three and thirty four one hundreds percent (33.34%) for year three) of the shares subject to the option will vest in three (3) annual installments commencing on the first anniversary of the date of grant such that the option is fully vested on the third anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date.

Content

Thirty three and thirty three one hundreds percent (33.33%) (and thirty three and thirty four one hundreds percent (33.34%) for year three) of the shares subject to the option will vest in three (3) annual installments commencing on the first anniversary of the date of grant such that the option is fully vested on the third anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date.